Cargando…
Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma
SIMPLE SUMMARY: The best therapy for patients with multiple HCC within the Milan Criteria is liver transplantation (LT). However, LT cannot be offered to all the patients. For the intermediate staged multiple HCC trans-arterial chemoembolization (TACE) still remains the treatment of choice. However,...
Autores principales: | Cassese, Gianluca, Han, Ho-Seong, Cho, Jai Young, Lee, Hae-Won, Lee, Boram, Troisi, Roberto Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737585/ https://www.ncbi.nlm.nih.gov/pubmed/36497478 http://dx.doi.org/10.3390/cancers14235997 |
Ejemplares similares
-
Leaping the Boundaries in Laparoscopic Liver Surgery for Hepatocellular Carcinoma
por: Cassese, Gianluca, et al.
Publicado: (2022) -
Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
por: Cassese, Gianluca, et al.
Publicado: (2022) -
Portal vein embolization failure: Current strategies and future perspectives to improve liver hypertrophy before major oncological liver resection
por: Cassese, Gianluca, et al.
Publicado: (2022) -
Preoperative Assessment and Perioperative Management of Resectable Gallbladder Cancer in the Era of Precision Medicine and Novel Technologies: State of the Art and Future Perspectives
por: Cassese, Gianluca, et al.
Publicado: (2022) -
Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives
por: Cassese, Gianluca, et al.
Publicado: (2023)